Clarivate for Life Sciences & Healthcare’s Post

While the diagnostics sector is moving forward, progress is extraordinarily slow. For decades, the industry has faced the same issues. Companies navigate technical, regulatory, and commercial risks, but reimbursement is crucial for investment returns. This slow pace can stifle innovations that could significantly advance the diagnostics industry. Watch our in-depth discussion on the current challenges and opportunities in diagnostics, here: https://lnkd.in/d7fxfkN7 #MedTech #Diagnostics #healthcareeconomy

To view or add a comment, sign in

Explore topics